Suppr超能文献

FTO 表达与胃癌临床病理特征及预后的关系的荟萃分析。

Meta-analysis of FTO expression on the clinicopathologic characteristics and prognosis of gastric cancer.

机构信息

The First Clinical Medicine College, Gansu University of Traditional Chinese Medicine, Lanzhou, China.

Department of Oncology Surgery, Gansu Provincial Hospital, Lanzhou, China.

出版信息

Medicine (Baltimore). 2024 Sep 27;103(39):e35714. doi: 10.1097/MD.0000000000035714.

Abstract

BACKGROUND

Fat mass and obesity-related gene (FTO) is aberrantly expressed in various cancers including highly expressed in gastric cancer tissues. The aim of this meta-analysis was to explore the effect of FTO expression on clinicopathological and prognostic outcome of gastric cancer.

METHODS

China National Knowledge Infrastructure (CNK), Wanfang database, VIP database, Chinese biomedical literature database (CBM), PubMed, Web of Science, the Cochrane library and EMBASE database were searched to screen the literatures according to the inclusion criteria. The search time was the database establishment until May 2023. The two researchers independently searched and screened the literature, extracted pathological data, and conducted The Newcastle-Ottawa scale (NOS) quality evaluation. Analyze the correlation between FTO and pathological indicators of gastric cancer patients and the impact on prognosis, use and Stata 12.0, software for Meta-analysis.

RESULTS

A total of 1619 patients were studied in this study. The results of the Meta-analysis showed that higher expression levels of FTO were associated with TMN stage (OR = 1.83, 95% CI: 1.11-3.03, P = .019), liver metastases (OR = 3.73, 95% CI: 1.49-9.31, P = .005), vascular invasion (OR = 2.22, 95% CI: 1.36-3.61, P = .001), poorer overall survival (OS) (HR = 0.46, 95% CI: 0.34-0.58, P < .001) and recurrence-free survival (HR = 0.56, 95% CI: 0.40-0.73, P < .001) in gastric cancer patients. There was no significant relationship with the degree of differentiation (OR = 1.08, 95% CI: 0.49-2.35, P = .852), age (OR = 0.89, 95% CI: 0.71-1.11, P = .306), and gender (OR = 0.92, 95% CI: 0.74-1.14, P = .432).

CONCLUSION

High expression of FTO was associated with risk of distant metastases and poor prognosis for patients with gastric cancer. FTO may be a potential prognostic biomarker for gastric cancer, but due to the limited number of literature, the above results need further research.

摘要

背景

脂肪量和肥胖相关基因(FTO)在各种癌症中异常表达,包括在胃癌组织中高表达。本荟萃分析的目的是探讨 FTO 表达对胃癌临床病理和预后结局的影响。

方法

我们在中国知网(CNKI)、万方数据库、维普数据库、中国生物医学文献数据库(CBM)、PubMed、Web of Science、Cochrane 图书馆和 EMBASE 数据库中进行搜索,根据纳入标准筛选文献。检索时间为数据库建立至 2023 年 5 月。两名研究人员独立搜索和筛选文献,提取病理数据,并进行纽卡斯尔-渥太华量表(NOS)质量评价。分析 FTO 与胃癌患者病理指标的相关性及其对预后的影响,采用 Stata 12.0 软件进行 Meta 分析。

结果

本研究共纳入 1619 例患者。Meta 分析结果显示,FTO 高表达与 TNM 分期(OR = 1.83,95%CI:1.11-3.03,P =.019)、肝转移(OR = 3.73,95%CI:1.49-9.31,P =.005)、血管侵犯(OR = 2.22,95%CI:1.36-3.61,P =.001)、总体生存(OS)(HR = 0.46,95%CI:0.34-0.58,P <.001)和无复发生存(HR = 0.56,95%CI:0.40-0.73,P <.001)较差相关。但与分化程度(OR = 1.08,95%CI:0.49-2.35,P =.852)、年龄(OR = 0.89,95%CI:0.71-1.11,P =.306)和性别(OR = 0.92,95%CI:0.74-1.14,P =.432)无显著相关性。

结论

FTO 高表达与胃癌患者远处转移风险和预后不良相关。FTO 可能是胃癌潜在的预后生物标志物,但由于文献数量有限,上述结果需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/11441928/d01843c6eecd/medi-103-e35714-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验